publication venue for
- 156 NT-proBNP predicts cardiovascular outcomes in patients with heart failure and preserved ejection fraction 2007
- 343 Depression in men with chronic heart failure: prevalence and hormone determinants 2007
- 344 Managing uncertainty in heart failure: preferences of physicians and patients regarding prognosis communication 2007
- 59 BNP predicts echocardiographic severity of diastolic dysfunction in heart failure 2007
- 677 Does andropause exist in men with chronic heart failure, and is it linked to multiple anabolic deficiency ? 2007
- 75 Oscillatory ventilation at rest coexisting with increased ventilatory response to exercise allow to identify heart failure patients with very poor outcome 2007
- 763 The use of independently programmable configurations to optimize sensing and pacing and to decrease re-operation rates in CRT patients 2007
- 856 The impact of heart failure on the characteristics and management of atrial fibrillation patients 2007
- 857 Serum hepcidin is not linked to iron status in patients with chronic heart failure 2007
- Anaemia is associated with poor outcome in patients with heart failure and preserved ejection fraction (HF-PEF). Findings from the I-PRESERVE trial. 7:86-86. 2008
- Atrial fibrillation is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial. 7:161-161. 2008
- Diabetes is associated with increased risk of CV events in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Systolic Function Trial. 7:2-2. 2008
- Predictors of outcome in heart failure with preserved ejection fraction: one year findings rom the Irbesartan in Heart Failure With Preserved Systolic Function Trial (I-PRESERVE). 7:87-87. 2008
- Renal dysfunction is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction - findings from the I-PRESERVE trial. 7:86-86. 2008
- The Canadian Cardiovascular Society (CCS) heart failure consensus conference program: shaping the future of heart failure management in Canada. 7:17-17. 2008